Tissues | Enrichment | No. of genes (Overlap NuMPa) | Adj. p | Other pathways |
---|---|---|---|---|
Heart | Oxidative phosphorylation | 101 (93) | 3.3e−53 | Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, NAFLD, carbon metabolism, Metabolic pathways, cardiac muscle contraction, TCA cycle, |
Leg muscle | Oxidative phosphorylation | 83 (38) | 1.0e−32 | Parkinson’s disease, Alzheimer’s disease, NAFLD, Huntington’s disease, Carbon metabolism, metabolic pathways, Proteasome, cardiac muscle contractionBiosynthesis of antibiotics |
Loin muscle | Oxidative phosphorylation | 89 (86) | 5.8e− 39 | Parkinson’s disease, Alzheimer’s disease, NAFLD, Huntington’s disease, Huntington’s disease, carbon metabolism, Proteosome, Cardiac muscle contraction |
Rib muscle | Oxidative phosphorylation | 86 (39) | 1.8e−35 | Parkinson’s disease, Alzheimer’s disease, NAFLD, Huntington’s disease, Metabolic pathways, carbon metabolism, Proteasome |
Tongue | Oxidative phosphorylation | 98 (91) | 3.0e−50 | Parkinson’s disease, Alzheimer’s disease, NAFLD, Huntington’s disease, Metabolic pathways, carbon metabolism, cardiac muscle contraction, |
Kidney cortex | Metabolic pathways | 312 (118) | 3.9e−28 | Biosynthesis of antibiotics, Carbon metabolism, Valine, leucine and isoleucine degradation, Glycine, serine and threonine metabolism, tryptophane metabolism, Fatty acid metabolism |
Kidney medulla | Focal adhesion | 67 (0) | 3.0e−10 | Tight junction, calcium signalling pathway, Gastric acid secretion. ECM-receptor interaction, cGMP-PKG signalling pathway, Gastric acid secretion, Dilated cardiomyopathy |
Liver | Metabolic pathways | 387 (123) | 4.1e−49 | Biosynthesis of antibiotics, Peroxisome, valine, leucine and isoleucine degradation, complement and coagulation cascades, fatty acid degradation, tryptophan metabolism, carbon metabolism |
Brain caudal lobe | Axon guidance | 57 (0) | 8.0e−18 | Glutamatergic Synapse, Domaminergic synapse, MAPK signalling pathway, Adrenergic signalling in cardiomyocytes, Retrograde endocannabinoid signalling, cAMP signalling pathway, Synaptic vesicle cycle, GABAergic synapse, Morphine addiction, Glutamatergic synapse, Circadian entrainment, Dopaminergic synapse |
Brain cerebellum | Glutamatergic synapse | 49 (2) | 3.1e− 14 | GABAergic synapse, Retrograde endocannabinoid signalling, Morphine addiction, Circadian entrainment, Dopaminergic synapse, cAMP signalling pathway, Adrenergic signalling in cardiomyocytes, axon guidance, |
Brain stem | GABAergic synapse | 36 (2) | 3.1e− 9 | Glutamergic synapse, Morphine addiction, Retrograde endocannabinoid signalling, Dopaminergic synapse, Circadian entrainment |
Leukocytes | Chemokine signalling pathways | 74 | 4.7e−15 | Focal adhesion, leukocyte transendothelial migration, Rap1 signalling pathway, natural killer cell mediated cytotoxicity, regulation of actin cytoskeleton, B cell receptor signalling pathway |